医学
肺活量测定
呼出气一氧化氮
哮喘
免疫球蛋白E
内科学
胃肠病学
免疫学
呼出气冷凝液
抗体
作者
Rory Chan,Chary Duraikannu,BJ Lipworth
标识
DOI:10.1183/13993003.congress-2022.4318
摘要
Introduction: Mucus plugging (MP) is recognised as a contributory factor to airway obstruction and symptoms in persistent asthma. We aimed to determine clinical predictors and phenotypic associations of mucus plugging in moderate-to-severe asthma in a real-life clinic setting. Methods: MPs were identified by a thoracic radiologist on HRCT. A MP score (MPS) was subsequently calculated and analysed along with type 2 (T2) biomarkers, spirometry, severe exacerbations and asthma control for 126 moderate to severe asthma patients. Results: Asthma patients with MP had significantly worse FEV1%, FEF25-75% and FEV1/FVC; higher levels of peripheral blood eosinophils, fractional exhaled nitric oxide, total IgE and A. fumigatus IgE titres associated with more frequent severe exacerbations. Adjusted odds ratios (95%CI) for prediction of MP were as follows: FEV1/FVC 3.01(1.14,7.97); ≥2 exacerbations/yr 5.00(1.55,16.11); blood eosinophils 3.23(1.16,8.96); total IgE 3.20(1.09,9.37); and A. fumigatus IgE titres 9.37(1.82,48.20). Conclusion: Poorly controlled asthma patients with MP exhibited significantly worse airflow obstruction, greater T2 inflammation associated with more frequent severe exacerbations. Spirometry, exacerbations, blood eosinophils, total IgE and A. fumigatus IgE were identified as real-life clinical predictors of MP. *p<0.05; **p<0.01 and ***p<0.001. Means±SD or median(IQR) presented.
科研通智能强力驱动
Strongly Powered by AbleSci AI